Aktis Oncology, Inc. (AKTS)

Last Closing Price: 16.40 (2026-11-19)

Cost of Goods Sold (Quarterly)

Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.

Aktis Oncology, Inc. (AKTS) Cost of Goods Sold data is not available.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
$3.90M
$-29.94M
Cost of Goods Sold
--
$3.90M
$38.65M
$-34.75M
$4.81M
$-29.94M
$-29.94M
$-29.94M
$-29.94M
$-29.94M
$-29.94M
$-34.75M
$-35.71M
55.65M
55.65M
$-0.54
$-0.54
Balance Sheet Financials
$499.89M
$15.37M
$32.60M
$532.48M
$35.16M
--
$38.45M
$73.61M
$458.87M
$458.87M
$458.87M
55.78M
Cash Flow Statement Financials
$-70.88M
$-237.99M
$339.41M
$38.93M
$69.47M
$30.54M
$9.69M
--
--
Fundamental Metrics & Ratios
14.22
--
--
--
--
100.00%
-889.81%
-889.81%
--
-766.68%
-766.68%
$-74.77M
--
--
--
0.01
--
--
--
-6.52%
-6.52%
-5.62%
-6.52%
$8.23
$-1.34
$-1.27